Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 47
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Biol Chem ; 298(2): 101579, 2022 02.
Artículo en Inglés | MEDLINE | ID: mdl-35031323

RESUMEN

Rho family small GTPases (Rho) regulate various cell motility processes by spatiotemporally controlling the actin cytoskeleton. Some Rho-specific guanine nucleotide exchange factors (RhoGEFs) are regulated via tyrosine phosphorylation by Src family tyrosine kinase (SFK). We also previously reported that PLEKHG2, a RhoGEF for the GTPases Rac1 and Cdc42, is tyrosine-phosphorylated by SRC. However, the details of the mechanisms by which SFK regulates RhoGEFs are not well understood. In this study, we found for the first time that PLEKHG1, which has very high homology to the Dbl and pleckstrin homology domains of PLEKHG2, activates Cdc42 following activation by FYN, a member of the SFK family. We also show that this activation of PLEKHG1 by FYN requires interaction between these two proteins and FYN-induced tyrosine phosphorylation of PLEKHG1. We also found that the region containing the Src homology 3 and Src homology 2 domains of FYN is required for this interaction. Finally, we demonstrated that tyrosine phosphorylation of Tyr-720 and Tyr-801 in PLEKHG1 is important for the activation of PLEKHG1. These results suggest that FYN is a regulator of PLEKHG1 and may regulate cell morphology through Rho signaling via the interaction with and tyrosine phosphorylation of PLEKHG1.


Asunto(s)
Factores de Intercambio de Guanina Nucleótido Rho , Proteínas de Unión al GTP rho , Familia-src Quinasas , Fosforilación , Factores de Intercambio de Guanina Nucleótido Rho/genética , Factores de Intercambio de Guanina Nucleótido Rho/metabolismo , Tirosina/metabolismo , Proteínas de Unión al GTP rho/genética , Proteínas de Unión al GTP rho/metabolismo , Familia-src Quinasas/genética , Familia-src Quinasas/metabolismo
2.
Immunohorizons ; 5(10): 870-883, 2021 10 26.
Artículo en Inglés | MEDLINE | ID: mdl-34702763

RESUMEN

Citrobacter rodentium is a murine pathogenic bacterium that adheres to intestinal epithelial cells, resulting in loss of microvilli and pedestal formation, and alters multiple cellular processes, including actin dynamics. Translocated intimin receptor (Tir), one of its virulence factors, functions as receptor for intimin, a bacterial adhesin, thereby mediating bacterial adhesion to epithelial cells. Although robust immune responses are induced to eliminate pathogenic bacteria in the host, they are suppressed against harmless commensal bacteria. The mechanism(s) underlying such a differentiation remains unclear. This study sought to determine the roles of intimate adhesion in the induction of specific immune responses upon C. rodentium infection. To this end, microbiota-depleted mice were infected with the Tir-F strain expressing full-length Tir or mutant strains expressing the C-terminal truncated Tir that is defective in intimin binding and host cell actin polymerization. There were no differences in the colonization kinetics and Abs responses against C. rodentium LPS among the strains, whereas Abs against the virulence factors were only produced on Tir-F infection. Although there were no differences in the virulence factors mRNA expression levels, colonic hyperplasia, and bacterial translocation to the systemic organs irrespective of the strain, adhesion to colonic epithelial cells was reduced in the mutant strain-infected mice. Furthermore, transcriptomic analysis indicated that robust inflammatory and immune responses were only induced in the Tir-F-infected group and were suppressed in the mutant-infected groups. Taken together, these findings suggest that Tir-mediated intimate adhesion induces inflammatory and immune responses, resulting in the induction of virulence factor-specific Abs.


Asunto(s)
Adhesión Bacteriana/inmunología , Citrobacter rodentium/inmunología , Infecciones por Enterobacteriaceae/inmunología , Mucosa Intestinal/patología , Factores de Virulencia/metabolismo , Adhesinas Bacterianas/metabolismo , Animales , Adhesión Bacteriana/genética , Línea Celular Tumoral , Citrobacter rodentium/genética , Citrobacter rodentium/patogenicidad , Infecciones por Enterobacteriaceae/microbiología , Infecciones por Enterobacteriaceae/patología , Femenino , Microbioma Gastrointestinal/inmunología , Mucosa Intestinal/inmunología , Mucosa Intestinal/microbiología , Ratones , Mutación , Receptores de Superficie Celular/genética , Receptores de Superficie Celular/metabolismo , Organismos Libres de Patógenos Específicos
3.
Biol Pharm Bull ; 43(12): 1911-1916, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33268709

RESUMEN

Royal jelly (RJ) is known as an important functional foodstuff that promotes several health benefits and contains various bioactive substances, including major royal jelly proteins (MRJPs). Among the MRJPs, MRJP3 possesses both cell proliferation and wound healing effects. As the carboxyl domain of MRJP3 contains tandem penta-peptide repeat (TPR) sequences unique to MRJP3 among the MRJPs, we purified the TPRs as glutathione-S-transferase (GST)-fusion proteins and demonstrated their dose-dependent effects on THP-1 and Vero cell proliferation. The GST-TPR protein with 19 repeats (GST-TPR19) showed cell proliferative activity equivalent to MRJP3 and higher than GST-TPR6. GST-TPR19 also exhibited wound healing activity at a level similar to MRJP3. Digestion of GST-TPR19 with trypsin had no effect on its cell proliferative activity, suggesting that the main digested products; i.e., penta-peptides (Q-N-x-N-[K/R]), maintain the cell proliferative ability of MRJP3. In conclusion, the TPRs of MRJP3 are critical to the beneficial effect(s) of RJ.


Asunto(s)
Proliferación Celular/efectos de los fármacos , Ácidos Grasos/química , Ácidos Grasos/genética , Oligopéptidos/química , Oligopéptidos/genética , Análisis de Secuencia de Proteína/métodos , Animales , Proliferación Celular/fisiología , Chlorocebus aethiops , Ácidos Grasos/farmacología , Humanos , Oligopéptidos/farmacología , Células THP-1 , Células Vero
4.
Cell Signal ; 61: 93-107, 2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-31100317

RESUMEN

The Rho family small GTPases mediate cell responses through actin cytoskeletal rearrangement. We previously reported that PLEKHG2, a Rho-specific guanine nucleotide exchange factor, is regulated via interaction with several proteins. We found that PLEKHG2 interacted with non-receptor tyrosine kinase ABL1, but the cellular function remains unclear. Here, we show that the interaction between PLEKHG2 and ABL1 attenuated the PLEKHG2-induced serum response element-dependent gene transcription in a tyrosine phosphorylation-independent manner. PLEKHG2 and ABL1 were co-localized and accumulated within cells co-expressing PLEKHG2 and ABL1. The cellular fractionation analysis suggested that the accumulation involved actin cytoskeletal reorganization. We also revealed that the co-expression of PLEKHG2 with ABL1, but not BCR-ABL, suppressed cell growth and synergistically enhanced NF-κB-dependent gene transcription. The cell growth suppression was canceled by co-expression with IκBα, a member of the NF-κB inhibitor protein family. This study suggests that the interaction between PLEKHG2 and ABL1 suppresses cell growth through intracellular protein accumulation via the NF-κB signaling pathway.


Asunto(s)
Proliferación Celular/genética , Factores de Intercambio de Guanina Nucleótido/metabolismo , FN-kappa B/metabolismo , Proteínas Proto-Oncogénicas c-abl/metabolismo , Transducción de Señal/genética , Citoesqueleto de Actina/metabolismo , Actinas/metabolismo , Proteínas de Fusión bcr-abl/metabolismo , Factores de Intercambio de Guanina Nucleótido/genética , Células HEK293 , Humanos , Inhibidor NF-kappaB alfa/metabolismo , Fosforilación/genética , Agregado de Proteínas/genética , Unión Proteica/genética , Proteínas Proto-Oncogénicas c-abl/genética , Elemento de Respuesta al Suero/genética , Transcripción Genética/genética , Transfección
5.
J Microbiol Methods ; 159: 62-68, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30817947

RESUMEN

Evaluation of the efficacy of vaccine candidates that prevent enteropathogenic and enterohemorrhagic Escherichia coli (EPEC/EHEC) infection in mouse models is difficult due to their limited pathogenicity in mice. Citrobacter rodentium, a murine pathogenic bacterium that shares its infection strategy and virulence genes with EPEC/EHEC, has been used as a model pathogen to develop novel vaccine strategies or platforms for these bacteria. However, there are few reports on the comparative effectiveness of novel vaccine platforms as no C. rodentium vaccines have yet been prepared by standard methods such as bacteria attenuation or inactivation. In this study, we investigated the protective effect of the oral administration of formalin-inactivated C. rodentium (Fo-CR) on C. rodentium infection in two mouse strains, C57BL/6 and C3H/HeN, as these strains have different degrees of susceptibility to infection. In C57BL/6 mice, administration of Fo-CR induced significant C. rodentium-specific mucosal and systemic antibody responses, promoted bacterial clearance from the gut and inhibited colonic hyperplasia. Furthermore, in C3H/HeN mice, the administration followed by lethal C. rodentium infection induced significantly high avidity serum IgG specific to C. rodentium and inhibited death, body weight loss, and bacterial invasion to visceral organs. In conclusion, the oral administration of Fo-CR resulted in the protection of mice from C. rodentium infection, indicating that it serves as a reference method for evaluating the efficacy of novel oral vaccine candidates or platforms.


Asunto(s)
Vacunas Bacterianas/administración & dosificación , Citrobacter rodentium/inmunología , Infecciones por Enterobacteriaceae/prevención & control , Administración Oral , Animales , Anticuerpos Antibacterianos/inmunología , Vacunas Bacterianas/inmunología , Citrobacter rodentium/genética , Infecciones por Enterobacteriaceae/inmunología , Infecciones por Enterobacteriaceae/microbiología , Femenino , Humanos , Inmunización , Inmunoglobulina G/inmunología , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Vacunas de Productos Inactivados/administración & dosificación , Vacunas de Productos Inactivados/inmunología
6.
Biol Pharm Bull ; 41(2): 190-197, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29386479

RESUMEN

Application of food-grade Lactococcus lactis (L. lactis) as a safe delivery tool for DNA vaccines and therapeutic proteins has been well investigated. Although some studies showed that eukaryotic expression plasmids were transferred from L. lactis to enterocytes, the precise mechanism of the DNA transfer remains unknown. In this study, we generated an invasive L. lactis strain that expresses "murinized" Internalin A, an invasin of intracellular bacteria Listeria monocytogenes with two amino acid alterations for invasion into murine cells, and confirmed that this L. lactis strain delivered DNA in an invasin-dependent manner into a monolayer of epithelial cells polarized to mimic the gastrointestinal tract environment. Although invasive L. lactis inoculated orally can deliver DNA into enterocytes in the gastrointestinal tract of mice, the efficiency of DNA transfer was similar to that of non-invasive L. lactis strain, suggesting that the in vivo DNA transfer from L. lactis occurs invasin-independently. A ligated-intestinal loop assay, a method for a short-term culturing of the whole intestine filled with materials to evaluate the interaction of the materials with intestinal cells, demonstrated that both non-invasive and invasive L. lactis strains were present in the Peyer's patches of the small intestine. On the other hand, few L. lactis was detected in the non-Peyer's patch epithelial region. Thus, our observations lead us to speculate that DNA transfer from L. lactis occurs predominantly in the Peyer's patches in an invasin-independent manner.


Asunto(s)
Proteínas Bacterianas/metabolismo , ADN Recombinante/metabolismo , Sistemas de Liberación de Medicamentos , Lactococcus lactis/fisiología , Microorganismos Modificados Genéticamente/fisiología , Ganglios Linfáticos Agregados/metabolismo , Vacunas de ADN/metabolismo , Administración Oral , Animales , Proteínas Bacterianas/administración & dosificación , Proteínas Bacterianas/química , Proteínas Bacterianas/genética , Traslocación Bacteriana , Transporte Biológico , Células CACO-2 , Línea Celular , Polaridad Celular , ADN Recombinante/administración & dosificación , Femenino , Microbiología de Alimentos , Humanos , Mucosa Intestinal/citología , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiología , Intestino Delgado/citología , Intestino Delgado/metabolismo , Intestino Delgado/microbiología , Lactococcus lactis/citología , Lactococcus lactis/genética , Listeria monocytogenes/citología , Listeria monocytogenes/genética , Listeria monocytogenes/fisiología , Ratones , Ratones Endogámicos C57BL , Microorganismos Modificados Genéticamente/citología , Microorganismos Modificados Genéticamente/genética , Ganglios Linfáticos Agregados/citología , Ganglios Linfáticos Agregados/microbiología , Proteínas Recombinantes de Fusión/administración & dosificación , Proteínas Recombinantes de Fusión/metabolismo , Vacunas de ADN/administración & dosificación
7.
Cell ; 163(2): 367-80, 2015 Oct 08.
Artículo en Inglés | MEDLINE | ID: mdl-26411289

RESUMEN

Intestinal Th17 cells are induced and accumulate in response to colonization with a subgroup of intestinal microbes such as segmented filamentous bacteria (SFB) and certain extracellular pathogens. Here, we show that adhesion of microbes to intestinal epithelial cells (ECs) is a critical cue for Th17 induction. Upon monocolonization of germ-free mice or rats with SFB indigenous to mice (M-SFB) or rats (R-SFB), M-SFB and R-SFB showed host-specific adhesion to small intestinal ECs, accompanied by host-specific induction of Th17 cells. Citrobacter rodentium and Escherichia coli O157 triggered similar Th17 responses, whereas adhesion-defective mutants of these microbes failed to do so. Moreover, a mixture of 20 bacterial strains, which were selected and isolated from fecal samples of a patient with ulcerative colitis on the basis of their ability to cause a robust induction of Th17 cells in the mouse colon, also exhibited EC-adhesive characteristics.


Asunto(s)
Adhesión Bacteriana , Citrobacter rodentium/fisiología , Infecciones por Enterobacteriaceae/inmunología , Infecciones por Escherichia coli/inmunología , Escherichia coli O157/fisiología , Mucosa Intestinal/inmunología , Células Th17/inmunología , Animales , Infecciones Bacterianas/inmunología , Células Epiteliales/inmunología , Células Epiteliales/microbiología , Células Epiteliales/ultraestructura , Heces/microbiología , Humanos , Inmunoglobulina A/inmunología , Mucosa Intestinal/microbiología , Mucosa Intestinal/patología , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos , Microscopía Electrónica de Rastreo , Ratas , Ratas Endogámicas F344 , Especificidad de la Especie
8.
J Biol Chem ; 289(14): 10045-56, 2014 Apr 04.
Artículo en Inglés | MEDLINE | ID: mdl-24554703

RESUMEN

FLJ00018/PLEKHG2 is a guanine nucleotide exchange factor for the small GTPases Rac and Cdc42 and has been shown to mediate the signaling pathways leading to actin cytoskeleton reorganization. The function of FLJ00018 is regulated by the interaction of heterotrimeric GTP-binding protein Gßγ subunits or cytosolic actin. However, the details underlying the molecular mechanisms of FLJ00018 activation have yet to be elucidated. In the present study we show that FLJ00018 is phosphorylated and activated by ß1-adrenergic receptor stimulation-induced EGF receptor (EGFR) transactivation in addition to Gßγ signaling. FLJ00018 is also phosphorylated and activated by direct EGFR stimulation. The phosphorylation of FLJ00018 by EGFR stimulation is mediated by the Ras/mitogen-activated protein kinase (MAPK) pathway. Through deletion and site-directed mutagenesis studies, we have identified Thr-680 as the major site of phosphorylation by EGFR stimulation. FLJ00018 T680A, in which the phosphorylation site is replaced by alanine, showed a limited response of the Neuro-2a cell morphology to EGF stimulation. Our results provide evidence that stimulation of the Ras/MAPK pathway by EGFR results in FLJ00018 phosphorylation at Thr-680, which in turn controls changes in cell shape.


Asunto(s)
Receptores ErbB/metabolismo , Factores de Intercambio de Guanina Nucleótido/metabolismo , Sistema de Señalización de MAP Quinasas/fisiología , Activación Transcripcional/fisiología , Sustitución de Aminoácidos , Animales , Forma de la Célula , Receptores ErbB/genética , Factores de Intercambio de Guanina Nucleótido/genética , Células HEK293 , Humanos , Ratones , Mutagénesis Sitio-Dirigida , Mutación Missense , Células 3T3 NIH , Fosforilación
9.
Biomed Res ; 34(4): 205-14, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23995057

RESUMEN

Toll-like receptors (TLRs) play a critical role in innate immunity by recognizing pathogen-associated molecular patterns. Various environmental materials including lipids may affect TLR signaling and modulate innate immune responses. We previously reported that 10-hydroxy-trans-2-decenoic acid (10H2DA) inhibits lipopolysaccharide (LPS)-induced interleukin (IL)-6 and nitric oxide (NO) production via inhibiting NF-κB activation. In this study, we investigated the effect of 10-hydroxydecanoic acid (10HDA), a saturated fatty acid of 10H2DA, on LPS-induced cytokines/chemokines and NO production. 10HDA inhibited LPS-induced NO production, but not tumor necrosis factor-α or IL-6 production. LPS-induced activation of interferon (IFN)-stimulated response element, but not NF-κB, was inhibited by 10HDA. Phosphorylation of STAT1 and STAT2 was not affected, but IFN-regulatory factor (IRF)-1 production was significantly reduced by 10HDA. The LPS-induced increase of IRF-1 mRNA, however, was not affected by 10HDA. We found that IRF-1 mRNA level in the polysomal fraction was significantly decreased by 10HDA. Further, LPS-induced phosphorylation of Akt and 4E-BP1, which control mRNA translation, was markedly decreased. These results suggest that 10HDA inhibited LPS-induced NO production through inhibiting IRF-1 translation. These findings elucidate a novel mechanism for anti-inflammatory activity of medium-chain fatty acid 10HDA.


Asunto(s)
Ácidos Grasos Monoinsaturados/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Factor 1 Regulador del Interferón/genética , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Óxido Nítrico/biosíntesis , Biosíntesis de Proteínas , Proteínas Adaptadoras Transductoras de Señales , Animales , Proteínas Portadoras/metabolismo , Proteínas de Ciclo Celular , Línea Celular , Citocinas/biosíntesis , Citocinas/genética , Ácidos Decanoicos , Factores Eucarióticos de Iniciación , Factor 1 Regulador del Interferón/metabolismo , Factores Reguladores del Interferón/genética , Factores Reguladores del Interferón/metabolismo , Lipopolisacáridos/inmunología , Macrófagos/inmunología , Ratones , FN-kappa B/metabolismo , Óxido Nítrico Sintasa de Tipo II/metabolismo , Fosfoproteínas/metabolismo , Fosforilación , Proteínas Proto-Oncogénicas c-akt/metabolismo , Factor de Transcripción STAT1/metabolismo , Factor de Transcripción STAT2/metabolismo , Transducción de Señal
10.
Cell Signal ; 25(1): 41-9, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23000341

RESUMEN

FLJ00018/PLEKHG2 is a guanine nucleotide exchange factor for the Rho family small GTPases. FLJ00018 is directly activated by heterotrimeric G protein Gßγ subunits. Using two-hybrid screening, we have identified non-muscle cytosolic actin as a binding partner of FLJ00018. We found that there were two actin-binding regions in FLJ00018 at the N-terminal region (150-283 amino acids) and at the C-terminal region (465-1386 amino acids). The overexpression of non-muscle cytosolic actin attenuated the FLJ00018-induced serum response element-dependent gene transcription. These results suggest that non-muscle cytosolic actin may be a negative regulator of FLJ00018 through its interaction with the Dbl homology domain.


Asunto(s)
Actinas/metabolismo , Factores de Intercambio de Guanina Nucleótido/metabolismo , Actinas/genética , Animales , Subunidades beta de la Proteína de Unión al GTP/genética , Subunidades beta de la Proteína de Unión al GTP/metabolismo , Subunidades gamma de la Proteína de Unión al GTP/genética , Subunidades gamma de la Proteína de Unión al GTP/metabolismo , Factores de Intercambio de Guanina Nucleótido/química , Factores de Intercambio de Guanina Nucleótido/genética , Células HEK293 , Humanos , Ratones , Células 3T3 NIH , Unión Proteica , Estructura Terciaria de Proteína , Elemento de Respuesta al Suero , Transcripción Genética , Transfección , Técnicas del Sistema de Dos Híbridos
11.
Immunopharmacol Immunotoxicol ; 35(1): 1-7, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22856509

RESUMEN

The extracts prepared from green algae are reported to possess a variety of biological activities including antioxidant, antitumor and antiviral activities. The acidic polysaccharide fraction from a green alga Coccomyxa gloeobotrydiformi (CmAPS) was isolated and the antiviral action on an in vitro infection of influenza A virus was examined. CmAPS inhibited the growth and yield of all influenza A virus strains tested, such as A/H1N1, A/H2N2, A/H3N2 and A/H1N1 pandemic strains. The 50% inhibitory concentration of CmAPS on the infection of human influenza A virus strains ranged from 26 to 70 µg/mL and the antiviral activity of CmAPS against influenza A/USSR90/77 (H1N1) was the strongest. The antiviral activity of CmAPS was not due to the cytotoxicity against host cells. The antiviral activity of CmAPS required its presence in the inoculation of virus onto MDCK cells. Pretreatment and post-treatment with CmAPS was ineffective for the antiviral activity. CmAPS inhibited influenza A virus-induced erythrocyte hemagglutination and hemolysis. Taken together, CmAPS was suggested to exhibit the anti-influenza virus activity through preventing the interaction of virus and host cells. The detailed antiviral activity of CmAPS is discussed.


Asunto(s)
Antivirales/química , Antivirales/farmacología , Chlorophyta/química , Virus de la Influenza A/efectos de los fármacos , Gripe Humana/virología , Extractos Vegetales/farmacología , Polisacáridos/química , Polisacáridos/farmacología , Animales , Células Cultivadas , Pollos , Perros , Eritrocitos/efectos de los fármacos , Hemaglutinación/efectos de los fármacos , Hemólisis/efectos de los fármacos , Interacciones Huésped-Patógeno/efectos de los fármacos , Humanos , Gripe Humana/tratamiento farmacológico , Células de Riñón Canino Madin Darby , Extractos Vegetales/química , Replicación Viral/efectos de los fármacos
12.
Inflammation ; 36(2): 372-8, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23079939

RESUMEN

Royal jelly acid, 10-hydroxy-trans-2-decenoic acid (10H2DA), is a major lipid component of royal jelly, which is the exclusive diet of queen honeybees. Previously, we showed partial inhibition of lipopolysaccharide (LPS)-induced NF-κB activation by 10H2DA. In this study, the ability of 10H2DA to inhibit LPS-induced nitric oxide (NO) production was investigated. LPS-induced NO production and inducible NO synthase (iNOS) gene transcription were inhibited by 10H2DA. LPS-stimulated interferon (IFN)-ß production, IFN regulatory factor-1 induction and IFN-stimulated response element activation, which are required for iNOS induction, were unaffected by 10H2DA. IFN-ß-induced NO production, however, was significantly inhibited by 10H2DA. Furthermore, IFN-ß-induced nuclear factor (NF)-κB activation and tumour necrosis factor (TNF)-α production were significantly inhibited by 10H2DA, and TNF-α-induced NF-κB activation was also inhibited by 10H2DA. These results and our previous study suggest that 10H2DA inhibits LPS- and IFN-ß-induced NO production via inhibition of NF-κB activation induced by LPS or IFN-ß.


Asunto(s)
Ácidos Grasos Monoinsaturados/farmacología , Interferón beta/metabolismo , Macrófagos/metabolismo , FN-kappa B/antagonistas & inhibidores , Óxido Nítrico/biosíntesis , Animales , Línea Celular , Factor 1 Regulador del Interferón/biosíntesis , Interferón beta/biosíntesis , Interferón beta/efectos de los fármacos , Lipopolisacáridos , Ratones , FN-kappa B/metabolismo , Óxido Nítrico Sintasa de Tipo II/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo II/biosíntesis , Óxido Nítrico Sintasa de Tipo II/genética , Elementos de Respuesta , Transcripción Genética/efectos de los fármacos , Factor de Necrosis Tumoral alfa/biosíntesis , Factor de Necrosis Tumoral alfa/metabolismo
13.
Artículo en Inglés | MEDLINE | ID: mdl-23061418

RESUMEN

Royal jelly is a food for queen and larvae honeybees. 10-Hydroxy-trans-2-decenoic acid (10H2DA; "royal jelly acid") is the principal lipid component in royal jelly. Several pharmacological activities of 10H2DA have been reported: anti-tumor, anti-biotic, immunomodulatory, estrogenic and neurogenic. We recently revealed an inhibitory effect of 10H2DA in innate immune signals. Despite appreciable advances in studies on innate immune signals after the identification of Toll-like receptors as innate immune receptors, few studies have reported the effect of 10H2DA on innate immune signals. In this review, we focus on recent advances in the evaluation of the biological activities of 10H2DA (especially immunomodulatory activities). We also discuss the molecular mechanisms underpinning these biological activities, which could lead to new therapeutic targets for the treatment of immune disorders.


Asunto(s)
Ácidos Grasos Monoinsaturados/química , Ácidos Grasos Monoinsaturados/farmacología , Ácidos Grasos/química , Ácidos Grasos/farmacología , Factores Inmunológicos , Inmunidad Adaptativa/efectos de los fármacos , Animales , Antineoplásicos/farmacología , Antirreumáticos/uso terapéutico , Artritis Reumatoide/tratamiento farmacológico , Colágeno/biosíntesis , Epigenómica , Humanos , Inmunidad Innata/efectos de los fármacos , Canales Iónicos/efectos de los fármacos , Neurogénesis/efectos de los fármacos , Receptores de Estrógenos/agonistas , Receptores de Estrógenos/antagonistas & inhibidores
14.
Mol Immunol ; 52(3-4): 299-304, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22750230

RESUMEN

2-Aminopurine (2-AP) is widely used as an inhibitor for double stranded RNA-dependent protein kinase (PKR). Previously, we reported that 2-AP inhibits Toll-like receptor (TLR) ligand-induced nitric oxide production through the prevention of interferon (IFN)-ß production. In this study, we investigated the mechanisms for 2-AP inhibition of lipopolysaccharide (LPS)-induced IFN-ß production. A reporter gene assay showed that LPS-induced IFN-ß promoter, but not nuclear factor (NF)-κB, activation was significantly inhibited by 2-AP. IFN-ß promoter activation induced by the overexpression of Toll/interleukin-1 receptor domain-containing adaptor inducing IFN-ß (TRIF) was significantly inhibited by 2-AP in a dose-dependent manner, while TRIF- or myeloid differentiation primary response gene 88-dependent NF-κB activation was not inhibited. IFN-ß promoter activation induced by expression of the downstream signaling molecules, tumor necrosis factor receptor-associated factor family member-associated NF-κB activator-binding kinase 1, inhibitor of NF-κB kinase i and a constitutively active mutant of interferon regulatory factor (IRF)-3, was also inhibited by 2-AP. Another PKR inhibitor harboring the imidazolo-oxindole structure, however, did not affect TRIF signaling molecules-induced IFN-ß promoter activation, suggesting that the inhibition of IFN-ß transcription by 2-AP is independent of PKR inhibition. Further, we examined the effect of 2-AP on LPS-induced IRF-3 activation by immunoblotting. While 2-AP did not affect LPS-induced phosphorylation of IRF-3, nuclear translocation of IRF-3 was inhibited. Moreover, we revealed that LPS-induced phosphorylation of Akt, another key molecule involved in IRF-3 activation, was inhibited by 2-AP. These results suggest that 2-AP inhibits nuclear translocation of phosphorylated-IRF-3 by inhibiting Akt activation.


Asunto(s)
2-Aminopurina/farmacología , Proteínas Adaptadoras del Transporte Vesicular/antagonistas & inhibidores , Interferón beta/biosíntesis , Lipopolisacáridos/inmunología , Regiones Promotoras Genéticas/efectos de los fármacos , Células 3T3 , Proteínas Adaptadoras del Transporte Vesicular/biosíntesis , Animales , Línea Celular , Genes Reporteros , Factor 3 Regulador del Interferón/antagonistas & inhibidores , Factor 3 Regulador del Interferón/biosíntesis , Interferón beta/genética , Interleucina-1/biosíntesis , Macrófagos/inmunología , Ratones , Factor 88 de Diferenciación Mieloide/metabolismo , FN-kappa B/biosíntesis , Proteínas Proto-Oncogénicas c-akt/antagonistas & inhibidores , Proteínas Proto-Oncogénicas c-akt/metabolismo , Transducción de Señal/efectos de los fármacos , Péptidos y Proteínas Asociados a Receptores de Factores de Necrosis Tumoral/biosíntesis
15.
Biol Pharm Bull ; 35(6): 917-23, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22687484

RESUMEN

Previously, we have shown that chickens immunized with Shiga toxin (Stx) produce Stx-neutralizing egg yolk immunoglobulin Y (IgY) antibody. The anti-Stx-1 IgY and anti-Stx-2 IgY exert their neutralizing activity through their antibody activity against the B subunit of the toxin but not the A subunit. In the present study, chickens were immunized with recombinant Stx-1 B subunit (rStx-1B) and recombinant Stx-2 B subunit (rStx-2B). Induced anti-rStx-1B and anti-rStx-2B IgY neutralized the toxicity of Stx-1 and Stx-2 against HeLa 229 cells. The neutralizing activity of anti-rStx-1B IgY on Stx-1 was almost 10 times stronger than that of anti-Stx-1 IgY, and that of anti-rStx-2B IgY was 2.6 times stronger than that of anti-Stx-2 IgY. Anti-rStx-1B and anti-rStx-2B IgY reacted with multimeric and monomeric forms of the B subunits in contrast to anti-Stx-1 and anti-Stx-2 IgY that reacted with only the multimeric form. These results indicated that recombinant B subunits were promising antigens for induction of neutralizing antibodies in chickens.


Asunto(s)
Anticuerpos Neutralizantes/inmunología , Yema de Huevo/inmunología , Inmunoglobulinas/inmunología , Toxina Shiga/inmunología , Animales , Pollos , Ensayo de Inmunoadsorción Enzimática , Inmunización , Subunidades de Proteína/inmunología , Proteínas Recombinantes/inmunología
16.
Innate Immun ; 18(3): 429-37, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21948282

RESUMEN

The effect of 10-hydroxy-trans-2-decenoic acid (10H2DA), a major fatty acid component of royal jelly, was investigated on LPS-induced cytokine production in murine macrophage cell line, RAW264 cells. 10H2DA inhibited LPS-induced IL-6 production dose-dependently, but did not inhibit TNF-α production. 10H2DA inhibited LPS-induced NF-κB activation in a dose-dependent fashion. In addition, NF-κB activation induced by over-expression of either MyD88 or Toll/IL-1 receptor domain-containing adaptor inducing IFN-ß (TRIF) was also inhibited by 10H2DA. Degradation of IκB-α and phosphorylation of IκB kinase-α were not inhibited by 10H2DA. On the other hand, reduction of LPS-induced IκB-ζ expression was discovered. Production of lipocalin-2 and granulocyte colony-stimulating factor (G-CSF), which is dependent on IκB-ζ, was also inhibited by 10H2DA, whereas that of IκB-ζ-independent cytokines/chemokines, such as IFN-ß, murine monocyte chemotactic protein-1 (JE), macrophage inflammatory protein (MIP)-1α and MIP-2, was not. Together, 10H2DA specifically inhibited LPS-induced IκB-ζ expression, followed by inhibition of IκB-ζ-dependent gene production. These results suggest that 10H2DA is one of the components of royal jelly to show anti-inflammatory effects and could be a therapeutic drug candidate for inflammatory and autoimmune diseases associated with IκB-ζ and IL-6 production.


Asunto(s)
Antiinflamatorios/farmacología , Ácidos Grasos Monoinsaturados/farmacología , Quinasa I-kappa B/metabolismo , Interleucina-6/metabolismo , Macrófagos/inmunología , Proteínas de Fase Aguda/genética , Proteínas de Fase Aguda/metabolismo , Animales , Antiinflamatorios/química , Línea Celular , Regulación hacia Abajo , Ácidos Grasos/química , Ácidos Grasos Monoinsaturados/química , Factor Estimulante de Colonias de Granulocitos/genética , Factor Estimulante de Colonias de Granulocitos/metabolismo , Quinasa I-kappa B/genética , Interleucina-6/genética , Lipocalina 2 , Lipocalinas/genética , Lipocalinas/metabolismo , Lipopolisacáridos/inmunología , Lipopolisacáridos/metabolismo , Activación de Macrófagos/efectos de los fármacos , Macrófagos/efectos de los fármacos , Ratones , Proteínas Oncogénicas/genética , Proteínas Oncogénicas/metabolismo
17.
Biochem Biophys Res Commun ; 417(4): 1127-32, 2012 Jan 27.
Artículo en Inglés | MEDLINE | ID: mdl-22206674

RESUMEN

The glial cells missing a (GCMa) transcription factor plays a pivotal role in the placental development by regulating the expression of several genes in the placenta that are responsible for the proper formation of the syncytiotrophoblast. It is well known that the function of GCMa is regulated at both transcriptional and post-translational levels by the cyclic AMP (cAMP)/protein kinase A (PKA)-dependent pathway, the activation of which increases the GCMa protein level and leads to trophoblast differentiation into the syncytiotrophoblast. However, little is known about the regulatory control of GCMa by PKC-dependent signaling mechanism(s). To investigate whether GCMa is regulated by PKC-dependent pathway, we treated the human choriocarcinoma JEG-3 cells with phorbol 12-myristate 13-acetate (PMA) and studied its effect on the GCMa protein using a monoclonal anti-GCMa antibody we prepared. PMA caused a transient decrease in the endogenous GCMa protein level in JEG-3 cells that was accompanied by an increase in GCMa phosphorylation. The phosphorylation and degradation of GCMa by PMA treatment was effectively reduced by pretreatment with protein kinase C (PKC) inhibitors and a mitogen-activated protein kinase (MAPK) kinase (MEK) inhibitor, indicating a PKC- and MEK-dependent mechanism. Furthermore, we identified the serine residues 328, 378 and 383 to be the phosphorylation sites on GCMa that are involved in the PMA-induced degradation of GCMa. Our data demonstrate for the first time that GCMa is phosphorylated by the PKC- and MEK/extracellular signal-regulated kinase (ERK)-dependent mechanism, and that this phosphorylation is involved in its degradation process.


Asunto(s)
Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Proteínas Nucleares/metabolismo , Proteína Quinasa C/metabolismo , Acetato de Tetradecanoilforbol/metabolismo , Factores de Transcripción/metabolismo , Animales , Anticuerpos Monoclonales , Proteínas de Unión al ADN , Quinasas MAP Reguladas por Señal Extracelular/antagonistas & inhibidores , Células HEK293 , Humanos , Hibridomas , Sistema de Señalización de MAP Quinasas , Ratones , Neuropéptidos/genética , Neuropéptidos/inmunología , Neuropéptidos/metabolismo , Proteínas Nucleares/genética , Proteínas Nucleares/inmunología , Fosforilación , Inhibidores de Proteínas Quinasas/farmacología , Estabilidad Proteica , Serina/genética , Serina/metabolismo , Acetato de Tetradecanoilforbol/farmacología , Factores de Transcripción/genética , Factores de Transcripción/inmunología
18.
Cell Immunol ; 273(1): 73-8, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22177846

RESUMEN

10-Hydroxy-trans-2-decenoic acid (10H2DA) is a major lipid component of royal jelly, a honey bee secretion used to nourish the queen bee and young larvae. In this study, we examined the effect of 10H2DA on interferon (IFN)-γ-induced nitric oxide (NO) production. IFN-γ-induced NO production and activation of the inducible NO synthase promoter were significantly inhibited by 10H2DA. IFN-γ-induced phosphorylation of signal transducer and activator of transcription-1 was not affected by 10H2DA. In contrast, IFN-γ-induced tumor necrosis factor (TNF)-α production and nuclear factor (NF)-κB activation were inhibited by 10H2DA. IFN-γ-mediated induction of interferon regulatory factor (IRF)-8, but not IRF-1, was also inhibited by 10H2DA. IFN-γ-induced TNF-α production followed by activation of NF-κB is known to be essential for NO production. Together, 10H2DA inhibited IFN-γ-induced NO production by inhibiting IRF-8 induction and TNF-α production. 10H2DA might modulate IFN-γ-mediated cellular responses by inhibiting the induction of IRF-8 and IRF-8-dependent genes.


Asunto(s)
Ácidos Grasos Monoinsaturados/farmacología , Factores Reguladores del Interferón/antagonistas & inhibidores , Interferón gamma/antagonistas & inhibidores , Macrófagos/efectos de los fármacos , Óxido Nítrico/biosíntesis , Animales , Línea Celular , Activación Enzimática/inmunología , Ácidos Grasos/farmacología , Factores Reguladores del Interferón/genética , Factores Reguladores del Interferón/inmunología , Interferón gamma/inmunología , Macrófagos/enzimología , Macrófagos/inmunología , Ratones , FN-kappa B/inmunología , Óxido Nítrico/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo II/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo II/genética , Óxido Nítrico Sintasa de Tipo II/inmunología , ARN Mensajero/química , ARN Mensajero/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor de Transcripción STAT1/inmunología , Transcripción Genética/inmunología , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/inmunología
19.
PLoS One ; 6(10): e26526, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22028896

RESUMEN

Shiga toxins (Stxs) are involved in the development of severe systemic complications associated with enterohemorrhagic Escherichia coli (EHEC) infection. Various neutralizing agents against Stxs are under investigation for management of EHEC infection. In this study, we immunized chickens with formalin-inactivated Stx-1 or Stx-2, and obtained immunoglobulin Y (IgY) from the egg yolk. Anti-Stx-1 IgY and anti-Stx-2 IgY recognized the corresponding Stx A subunit and polymeric but not monomeric B subunit. Anti-Stx-1 IgY and anti-Stx-2 IgY suppressed the cytotoxicity of Stx-1 and Stx-2 to HeLa 229 cells, without cross-suppressive activity. The suppressive activity of these IgY was abrogated by pre-incubation with the corresponding recombinant B subunit, which suggests that the antibodies directed to the polymeric B subunits were predominantly involved in the suppression. In vivo, the intraperitoneal or intravenous administration of these IgY rescued mice from death caused by intraperitoneal injection of the corresponding toxin at a lethal dose. Moreover, oral administration of anti-Stx-2 IgY reduced the mortality of mice infected intestinally with EHEC O157:H7. Our results therefore suggest that anti-Stx IgY antibodies may be considered as preventive agents for Stx-mediated diseases in EHEC infection.


Asunto(s)
Proteínas del Huevo/inmunología , Infecciones por Escherichia coli/prevención & control , Inmunización/métodos , Inmunoglobulinas/inmunología , Toxina Shiga I/inmunología , Toxina Shiga II/inmunología , Administración Oral , Animales , Especificidad de Anticuerpos , Pollos , Reacciones Cruzadas/inmunología , Proteínas del Huevo/administración & dosificación , Escherichia coli Enterohemorrágica/inmunología , Escherichia coli Enterohemorrágica/patogenicidad , Heces , Femenino , Humanos , Inmunoglobulinas/administración & dosificación , Masculino , Ratones , Pruebas de Neutralización , Especificidad de la Especie
20.
J Virol ; 85(9): 4606-11, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21345944

RESUMEN

Plasmacytoid dendritic cells (pDCs) do not produce alpha interferon (IFN-α) unless viruses cause a systemic infection or overcome the first-line defense provided by conventional DCs and macrophages. We show here that even paramyxoviruses, whose infections are restricted to the respiratory tract, have a V protein able to prevent Toll-like receptor 7 (TLR7)- and TLR9-dependent IFN-α induction specific to pDCs. Mutational analysis of human parainfluenza virus type 2 demonstrates that the second Trp residue of the Trp-rich motif (Trp-X(3)-Trp-X(9)-Trp) in the C-terminal domain unique to V, a determinant for IRF7 binding, is critical for the blockade of TLR7/9-dependent signaling.


Asunto(s)
Células Dendríticas/inmunología , Células Dendríticas/virología , Virus de la Parainfluenza 2 Humana/patogenicidad , Transducción de Señal , Receptor Toll-Like 7/antagonistas & inhibidores , Receptor Toll-Like 9/antagonistas & inhibidores , Proteínas Virales/metabolismo , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...